• Achieved full-wafer manufacturing runs of quantum chip components
• Demonstrated proof-of-concept quantum neural network for fraud detection
• Completed $7 million share placement to strengthen balance sheet
• Advanced Biochip beta prototype for enhanced diagnostic capabilities
• Filed additional patent applications for Biochip technology

Archer Materials Limited, a quantum technology company, reported its Q4 FY26 activities, highlighting advancements across its technology portfolio. Key achievements include full-wafer manufacturing runs of refined 12CQ quantum chip components, progressing toward a functional qubit demonstration. The company also demonstrated proof-of-concept quantum neural network performance for fraud detection in both simulation and quantum hardware environments. Archer completed a well-supported $7 million share placement, strengthening its balance sheet. Additionally, the Biochip beta prototype saw significant advancements, including enhanced cartridge design, electronic readout, and control systems. The company filed additional patent applications to protect its Biochip intellectual property. Archer also entered into a strategic partnership with IonQ, Inc., leveraging IonQ's quantum compute power for algorithm development and deployment.

Archer is positioned to be at the center of developing quantum technologies that are scientifically differentiated, scalable, and designed to integrate seamlessly into existing semiconductor supply chains.